Roche, Atea Pharmaceuticals partner on COVID-19 oral treatment
The two companies are working together to develop AT-527, an orally administered, direct-acting antiviral therapy for patients diagnosed with COVID-19.
Archives for October 27, 2020
Saama introduces ASAP pharmacovigilance platform
Built with Gilead, the RWD-based technology is designed to offer pharma firms and research partners a more effective way to verify product safety.
Care Access Research, Lilly join on mobile COVID-19 trials
The clinical research solutions firm is joining forces with pharma giant Eli Lilly to manage mobile research of the monoclonal antibody LY-CoV555.